ASLAN Pharmaceuticals(Nasdaq: ASLN) is an Asia enabled pharmaceutical company that develops novel medicines for global markets. Headquartered in Singapore, ASLAN licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases, and uses high quality and efficient Asian development resources to progress the drugs through clinical development.
GI Dynamics (ASX: GID.AX)is a Lexington MA-based medical device company pioneering the development of effective, non-surgical treatments for the large and growing global populations with type 2 diabetes and obesity with its commercialized product EndoBarrier®.
Mach 7 Technologies(ASX: M7T)is a Singapore headquartered company which helps healthcare enterprises meet sophisticated medical imaging challenges with innovative, flexible software products and solutions. As a leader in the healthcare image data management market, Mach7 incorporates the newest DICOM and HL7 standards in its vendor neutral medical imaging solutions.
Paratek Pharmaceuticals (NASDAQ: PRTK), a Boston MA and biopharmaceuticals company engaged in the discovery and commercialization of new therapeutics for the infectious disease market to combat the problem of antibiotic resistance.
Private Investments (INCLUDING THOSE HELD BY ASSOCIATES)
BioMers is a Singapore headquartered medical device company that speciailizes in the development of novel polymer composite technology for biomedical applications. Through its patented technology breakthrough, BioMers introduced SimpliClear, the world's only completely clear orthodontic solution that is used to treat a wide spectrum of teeth irregularities, from mild to complex cases.
Clearbridge BioMedics is a National University of Singapore spin-off company which aims to be a leader in oncology diagnostics platforms. Its technology enables the label-free isolation, enumeration and retrieval of viable Circulating Tumour Cells (CTCs) from blood and is paving the next generation non-invasive 'liquid biopsy' for cancer.
CXA Group is a corporate benefits aggregator founded in 2013 by industry veteran Rosaline Chow Koo. CXA brings evidence-based wellness into the workplace to improve employee health and control healthcare costs. It is Asia’s first benefits and wellness marketplace platform and acquired Singapore’s largest homegrown employee benefits brokerage.
MerLion Pharmaceuticals is a Singapore company focusing on the discovery and development of new drug candidates from natural sources. It is progressing a novel, highly differentiated antibacterial candidate for the treatment of urinary tract infections and the eradication of Helicobacter pylori in critical care and hospital indications.
Sense.ly Inc. develops a remote assessment/virtual clinical assistant hub that helps clinicians manage their chronically ill patients. Its solution keeps a medical patient engaged as they communicate their symptoms, medical history, and recovery progress on mobile phones, Web, or television platforms to the medical community by using speech recognition, body recognition, augmented reality, video, and medical devices. The company was incorporated in 2013 and is headquartered in San Francisco, California.
Singapore Advanced Biologics is a Duke-NUS spinoff founded by two entrepreneurial researchers at the Duke-NUS Graduate Medical School to provide "Made in Singapore" specialised biologics to the growing biomedical science industry in Singapore and the region. It is initially focus on the design, synthesis and validation of specialised biologics, with an initial focus on siRNA, DNA and antibodies.